Additional prognostic effect of sacubitril-valsartan and SLGT2-Inhibitors on optimal medical therapy in patients with non-ischaemic dilated cardiomyopathy
9 May 2026 (12:30 - 13:30)
Organised by: 
Abstract
Slides
About the speaker
Hospital Center of Montebelluna, Montebelluna (Italy)
7 More presentations in this session
Doctor A. Cersosimo (Barcelona, ES)
Doctor N. Andjelkovic (Belgrade, RS)
Access the full session
The Event
Heart Failure 2026
9 May 2026
12:30 CET
